No menu items!

Moderna’s vaccine produces antibodies with half a dose, study says

RIO DE JANEIRO, BRAZIL - If protection with a smaller dose is confirmed, this could potentially result in twice as many people being immunized with the same number of doses.

The Covid-19 vaccine developed by US biotechnology company Moderna produced antibodies with half a dose of the vaccine when compared to a full dose.

The study's findings were published on February 9th in peer-reviewed Vaccine journal.

If protection with a smaller dose is confirmed, this could potentially result in twice as many people being immunized with the same number of doses.

In the phase II randomized, double-blind . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?

Check out our other content